| 產品名稱 | Compound 120 - Atazanavir, deuterated | CTP 518 |
| 產品貨號 | Axon 1753 CAS [N.A.] MF C38H37D15N6O7.H2O4SMW 818.03 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description A partially dueterated analog of Atazanavir (Axon 1441), an oral HIV protease inhibitor; A deuterium-containing medicine with improved ADME properties; Compound 120 showed an approximately 50% increase in half life compared with Atazanavir. References Certificates Categories Extra info SL Harbeson et al. Azapeptide derivatives. Patent Concert Pharmaceuticals Inc. WO2008156632 (A1) Certificate of Analysis Material Safety Data Sheet Immunology Non Selective EC 3.4.23.16 Deuterated Protease inhibitor (see Axon 1441) Chemical name (3S,8S,9S,12S)-3-(1,1-dimethylethyl)-12-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-Pentaazatetradecanedioic acid, 1,14-di(methyl-d3) ester sulfate Parent CAS No. [1092540-56-1] Order Size Unit Price Stock 2 mg €115.00 In Stock |
| 產品價格 | 現貨詢價，電話：010-67529703 |
| 產品規格 | |
| 產品品牌 | axonmedchem |
| 產品概述 | |
| 產品詳情 |
Compound 120 - Atazanavir, deuterated | CTP 518Axon 1753 CAS [N.A.] MF C38H37D15N6O7.H2O4S
DescriptionA partially dueterated analog of Atazanavir (Axon 1441), an oral HIV protease inhibitor; A deuterium-containing medicine with improved ADME properties; Compound 120 showed an approximately 50% increase in half life compared with Atazanavir.
Deuterated Protease inhibitor (see Axon 1441)
Chemical name(3S,8S,9S,12S)-3-(1,1-dimethylethyl)-12-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-Pentaazatetradecanedioic acid, 1,14-di(methyl-d3) ester sulfate Parent CAS No.[1092540-56-1] |
| 產品資料 |
